Breckenridge Pharma`s Generic Rivaroxaban Receives Approval in the U.S.
Natco Pharma Limited vide its disclosure dated 8th September 2023 has informed that Celgene Corporation, Bristol Myers Squibb Company, Breckenridge Pharmaceutical and Natco Pharma Limited have been named defendants in an antitrust lawsuit in the US by Louisiana Health Service & Indemnity Company D/B/A Blue Cross and Blue Shield of Louisiana and HMO Louisiana, regarding Pomalidomide (POMALYST) capsules.
BRECKENRIDGE, Colo., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Breckenridge Distillery, the ‘World’s Highest Distillery,’ and Breckenridge Brewery return this season for the second ever Buddy Pass, a unique barrel-exchange program to create a limited-edition Imperial Stout Cask Finish Whiskey and a Whiskey Barrel-Aged Imperial Oatmeal Stout Beer. After selling out last year’s inaugural limited release in Colorado, Buddy Pass has expanded nationwide, entering 10 new markets and will hit retailers starting Oct. 24.
Breckenridge's Generic Bendamustine Hydrochloride Receives Approval in the U.S.
Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted approval of its Abbreviated New Drug...
Natco Pharma on Monday said its partner Breckenridge Pharmaceutical Inc has received approval from the US health regulator for generic Cabazitaxel intravenous powder used in the treatment of prostate cancer.
Breckenridge's Generic Cabazitaxel Receives Approval in US
BRECKENRIDGE, Colo., April 25, 2022 (GLOBE NEWSWIRE) -- For the second year, Breckenridge Distillery – the world’s highest distillery and most awarded craft distillery in the US – combines the art of blending whiskey and color in the second edition of the Collectors Art Series, a limited release bottle with local Denver Street artist and muralist, Alexandrea Pangburn. The new Breckenridge XO Cognac Cask Finish Whiskey label will feature Pangburn’s flora and fauna-inspired artwork on the Breckenridge Distillery mural behind Number Thirty-Eight in Denver’s RiNo Arts District. Featuring inviting aromatics of grape with a hint of clove and cinnamon, the special edition whiskey will be available in limited quantities exclusively at the Breckenridge Distillery and the Main Street Tasting Room in Breckenridge, Colorado for, $125, starting May 6.
BERLIN, Conn. , April 22, 2022 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted tentative approval of its Abbreviated New Drug Application for Dabigatran Etexilate Capsules (generic for Pradaxa®). This product development was a collaboration between Towa Pharmaceutical Europe, S.L. coupled with an external contract manufacturing organization. Breckenridge has the three strengths consistent with the brand – 75mg, 110mg, and 150mg. According to industry sales data, Pradaxa generated annual sales of $455 million during the twelve months ending February 2022.